|
|
Article: Entropin Reports Nine-Months Results.
- Article from:
- Pain & Central Nervous System Week
- Article date:
- January 21, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 JAN 21 - (NewsRx.com & NewsRx.net) -- Entropin, Inc., (ETOP, ETOPW) has reported financial results for the nine months ended September 30, 2001.
Highlights of first nine months of 2001 and subsequent weeks include:
* $9.4 million in cash, cash equivalents and short-term investments as of September 30, 2001
* Approximately $2.4 million cash used in operating activities during the first nine months of 2001
* Phase II/III clinical trial began September 25, 2001; protocol designed by Blue Ribbon panel of experts
* Mechanism of action studies progressing at Brigham & Women's Hospital at Harvard Medical School
* ...